Related Experiment Video
Updated: Jun 2, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Effectiveness of rotavirus vaccination in Spain
Federico Martinón-Torres1, Marta Bouzón Alejandro, Lorenzo Redondo Collazo
1Área de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Spain. federico.martinon.torres@sergas.es
Abstract:
With the aim of determining rotavirus vaccine effectiveness (RVVE) in Spain, from Oct-2008/Jun-2009, 467 consecutive children below 2 years old with acute gastroenteritis (AGE) were recruited using a pediatric research network (ReGALIP-www.regalip.org) that includes primary, emergency and hospital care settings. Of 467 enrolled children, 32.3% were rotavirus positive and 35.0% had received at least one dose of any rotavirus vaccine. RRVE to prevent any episode of rotavirus AGE was 91.5% (95% CI: 83.7%-95.6%). RVVE to prevent hospitalization by rotavirus AGE was 95.6% (85.6-98.6%). No differences in RVVE were found regarding the vaccine used. Rotavirus vaccines have showed an outstanding effectiveness in Spain.
Related Concept Videos
Poliomyelitis
Respiratory Syncytial Virus Disease
Bacterial Gastroenteritis
Vaccinations

